Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial

Patrick Tobbia1, MD; Bruce R. Brodie1*, MD; Bernhard Witzenbichler2, MD; Chris Metzger3, MD; Giulio Guagliumi4, MD; Jennifer Yu5, MD; Mirle A. Kellett6, MD; Thomas Stuckey1, MD; Martin Fahy7, MSc; Roxana Mehran5,7, MD; Gregg W. Stone7,8, MD